ACN

Black Owned Fintech Novae, Joins Direct Selling Association

Retrieved on: 
Friday, March 22, 2024
Pampered Chef, Freedom, Ambit Energy, Organization, Growth, White label, Hunger, DSA, Amway, ACN, Trust, Education, Ethics, Interview, Credit, E.I.N.S., Direct, Scentsy

CONYERS, Ga., March 22, 2024 /PRNewswire/ -- CEO Reco McCambry announced this week that Novae has been accepted into the Direct Selling Association after a unanimous vote by their Board of Directors.

Key Points: 
  • CONYERS, Ga., March 22, 2024 /PRNewswire/ -- CEO Reco McCambry announced this week that Novae has been accepted into the Direct Selling Association after a unanimous vote by their Board of Directors.
  • Members range from ubiquitous direct selling companies like ACN, Amway, Avon, Primerica, and Mary Kay to modern brands whose memberships may surprise readers like pawTree, Ambit Energy, Scentsy, and The Pampered Chef.
  • This mission is also reflected in Novae's direct sales business model, in which Novae sales professionals effectively own their own businesses.
  • It is this business model that the Direct Selling Association was created to support back in 1910.

Cairn Homes Plc: Holding(s) in Company

Retrieved on: 
Wednesday, March 13, 2024
LEI, ACN, Colonial

financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv:

Key Points: 
  • financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv:
    PM Capital Global Companies Fund (LEI: 549300G9AAH2W5NCIP82)
    PM Capital Enhanced Yield Fund (LEI: 549300HZRCOLTKE3LT85)
    PM Capital Global Long Fund (LEI: 549300JRD4CV9FOK2S31)
    PM Capital Global Opportunities Fund Ltd (LEI: 5493002RXP07KPHL2B32)
    Colonial First State Investments Ltd (ACN 002 348 352) as trustee for Commonwealth Specialist Fund 11 (LEI: 5493005W2U5Q75KEGB51)
    Colonial First State Investments Ltd (ACN 002 348 352) as trustee for Commonwealth Fixed Interest Fund 11 (LEI: 549300J04EXUIXPVSV26)
    11.
  • In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date]
    Done at Sydney, Australia on 23 February 2024.
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.

Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination

Retrieved on: 
Tuesday, February 27, 2024
ACN, Proxy, Telephone, Meeting, Combination, AOI, ADOC, Business, Business analyst, Eastern Time Zone, Physician, Sub

Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m.

Key Points: 
  • Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m.
  • There is no change to the location, the record date, the purpose or any of the proposals to be acted upon at the Meeting.
  • The reason for the postponement is that AOI is engaged in additional negotiations regarding potential financing to occur in connection with the closing of the Proposed Business Combination.
  • The record date for holders of EDOC’s shareholders for voting in the Meeting remains February 2, 2024 (the “Record Date”).

Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination

Retrieved on: 
Friday, February 23, 2024
ACN, Proxy, Telephone, Meeting, Combination, AOI, ADOC, Business, Business analyst, Physician, Sub

Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) --  EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024.

Key Points: 
  • Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) --  EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024.
  • There is no change to the location, the record date, the purpose or any of the proposals to be acted upon at the Meeting.
  • The reason for the postponement is that AOI is engaged in additional negotiations regarding potential financing to occur in connection with the closing of the Proposed Business Combination.
  • The record date for holders of EDOC’s shareholders for voting in the Meeting remains February 2, 2024 (the “Record Date”).

ZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million

Retrieved on: 
Monday, January 29, 2024
Manna, ACN Inc., Wind, Health, ACN, Global health, Partnership, Investment, Acquisition, VMA, USD, EUR, Telecommunications, Growth

The strategic partnership for Europe is expected to create growth through the synergies that arise in the joint networks.

Key Points: 
  • The strategic partnership for Europe is expected to create growth through the synergies that arise in the joint networks.
  • In connection with the agreement, ACN has expressed a desire to invest USD 1m in Zinzino through its holding company Manna Holdings, LLC ("Manna").
  • The company's board has, with the support of the registered issue authorization from the annual general meeting on 31 May 2023, today decided on a directed issue of 149 468 Zinzino B shares to Manna.
  • Through the Directed Issuance, the number of B shares in the Company increases by 149 468 to a total of 28 977 672.

Neora Acquires ACN Korea, Marking a New Chapter in Asia Pacific Expansion

Retrieved on: 
Thursday, January 25, 2024
Entrepreneurship, ACN, Telecommunications, Brand Partners, Acquisition, Emerge, Growth, Airline

DALLAS, Jan. 25, 2024 /PRNewswire/ -- Neora, LLC, a global leader in science-driven skincare and wellness products, is excited to announce the acquisition of ACN Korea, a prominent player in Korea's direct sales sector. This strategic move marks a significant milestone in Neora's ongoing expansion across the Asia Pacific region.

Key Points: 
  • This strategic move marks a significant milestone in Neora's ongoing expansion across the Asia Pacific region.
  • ACN Korea, known as the sole provider of direct sales telecommunications and essential services in Korea, has been a Top 20 company in its sector.
  • This acquisition brings together Neora's innovative product range and ACN Korea's unique market position, creating an unmatched platform for entrepreneurial growth in direct sales.
  • This transition underscores Neora's dedication to fostering innovation, growth, and success in the Korean and broader Asia Pacific markets.

Accenture to Expand Network of Generative AI Studios Across Asia Pacific and Latin America

Retrieved on: 
Monday, January 8, 2024
Networks, Data Management, Technology, Artificial Intelligence, Software, Ecosystem, Telecommunications, Mining, Renewable energy, AI, Insurance, Investment, Public sector, Data, ERP, ACN

Accenture [NYSE: ACN] is setting up generative AI studios in nine countries across Asia Pacific and Latin America to respond to growing client interest in the technology.

Key Points: 
  • Accenture [NYSE: ACN] is setting up generative AI studios in nine countries across Asia Pacific and Latin America to respond to growing client interest in the technology.
  • They also recognize that generative AI introduces new, unique risks that need consideration and mitigation,” said Leo Framil, CEO of Accenture Growth Markets.
  • The studios will be operational in January 2024, except in Argentina and Mexico which will join the network later this year.
  • Note to editors: * Generative AI Studios already exist.

The Arena Group Launches ‘Arena Creator Network:’ A Creator-Led Cultural Content Hub Powered by Iconic Brands for Unmatched Social Branded Opportunities

Retrieved on: 
Thursday, September 7, 2023
Software, Social Media, Media, Marketing, Advertising, Communications, Technology, Apps, Applications, Sport, Media Group, Partnership, Food, Travel, Senior, Formula One, Job Creators Network, Culture, ACN, OTT, Human, Google Analytics, Esports, Arena, Movement, YouTube Next Lab and Audience Development Group, Comscore, TheStreet, Journal, F1, Editorial, Sports Illustrated, Growth, Entertainment, Management, Video game

The programs deliver smart targeting through audience and interest matchmaking that is cost-efficient and effective, equipping brands to reach millions of consumers.

Key Points: 
  • The programs deliver smart targeting through audience and interest matchmaking that is cost-efficient and effective, equipping brands to reach millions of consumers.
  • Parade grew social referrals by 161% year over year from last year to this year, according to The Arena Group’s internal data.
  • The result is deeper through line, social-first content that will inform editorial coverage from our iconic brands.
  • It’s really a modern, creative media solution, built with purpose,” said Lindsay Calabrese, General Manager of Creator Network at The Arena Group.

Hyundai Most Awarded Brand in 2023 Best Cars for Teens List by U.S. News & World Report

Retrieved on: 
Tuesday, June 6, 2023
Safety, U.S. News & World Report, Parent, BlueLink Information Network, ACN, Hyundai Motor Company, Habit, Hyundai, News, SUV, Automotive industry, Film industry

"Every 2023 Hyundai comes standard with three key safety systems: Forward Collision Warning/Forward Automatic Emergency Braking , Lane Keep Assist /Lane Following, and Driver Attention Warning .

Key Points: 
  • "Every 2023 Hyundai comes standard with three key safety systems: Forward Collision Warning/Forward Automatic Emergency Braking , Lane Keep Assist /Lane Following, and Driver Attention Warning .
  • As well as a suite of optional SmartSense safety systems and Hyundai's BlueLink ® telematics technology including Automatic Crash Notification (ACN).
  • We applaud U.S. News & World Report for recognizing Hyundai's commitment in keeping all passengers and road users safe."
  • "Hyundai swept our 2023 Best Cars for Teens awards, winning the most categories overall and every new SUV category that we evaluated," said Jim Sharifi, managing editor of U.S. News Best Cars.

Amulet Capital Partners Acquires Alliance Clinical Network

Retrieved on: 
Monday, May 22, 2023
Professional Services, Health, Finance, Clinical Trials, Pharmaceutical, Biotechnology, Vaccine, Partnership, Avista Capital Partners, Gastroenterology, ACN, DRS, De novo, Pain, Dermatology, Patient, Clinical research, Neurology, ChromeOS, Pharmaceutical industry, Fine chemical, Medical imaging, Amulet

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced it has acquired Alliance Clinical Network (“ACN”), a leading comprehensive clinical site platform.

Key Points: 
  • Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced it has acquired Alliance Clinical Network (“ACN”), a leading comprehensive clinical site platform.
  • Headquartered in Dallas, Texas, ACN currently owns and operates six clinical research sites serving patients, leading pharmaceutical sponsors and contract research organizations (CROs) across three states:
    - Hope Clinical Research, Acclaim Clinical Research and 310 Clinical Research in California,
    - Excel Clinical Research in Nevada, and
    - Epic Clinical Research and Zenos Clinical Research in Texas.
  • ACN will continue to be led by Founder and Chief Executive Officer Anthony Abey, who will retain a significant ownership stake in the business.
  • In 2022, the company supported more than 75 unique clinical trials for 40+ sponsors ranging from emerging biotechs to large pharma.